I was around. The float was smaller because the company did a reverse split. I think it was one for four, taking the stock from the high 3's to around $14.00 per share. The price appreciated in anticipation of the FDA ruling on the 30-30 formulation of Nuedexta. Unfortunately, we had the Halloween Surprise in 2006, and had to start over.